Buy, Sell, Or Hold LLY Stock At $750?
1. Eli Lilly's stock dropped 6% due to slower obesity drug sales growth. 2. Q4 revenue forecast adjusted down by 5%, missing analysts' estimates. 3. LLY projects 2024 revenue of $45 billion, reflecting 32% growth. 4. Strong 2025 outlook anticipates revenue between $58 billion and $61 billion. 5. Potential approval for orforglipron could enhance future sales growth.